Phoenix Biotech Acquisition Price Prediction

PBAXUDelisted Stock  USD 10.87  0.00  0.00%   
At this time, The value of RSI of Phoenix Biotech's share price is at 54 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Phoenix Biotech, making its price go up or down.

Oversold Vs Overbought

54

 
Oversold
 
Overbought
The successful prediction of Phoenix Biotech's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Phoenix Biotech Acquisition, which may create opportunities for some arbitrage if properly timed.
Using Phoenix Biotech hype-based prediction, you can estimate the value of Phoenix Biotech Acquisition from the perspective of Phoenix Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Phoenix Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Phoenix because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Phoenix Biotech after-hype prediction price

    
  USD 10.87  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Phoenix Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
9.289.2811.96
Details
Naive
Forecast
LowNextHigh
10.6310.6310.63
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
10.8810.8810.88
Details

Phoenix Biotech After-Hype Price Prediction Density Analysis

As far as predicting the price of Phoenix Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Phoenix Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Phoenix Biotech, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Phoenix Biotech Estimiated After-Hype Price Volatility

In the context of predicting Phoenix Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Phoenix Biotech's historical news coverage. Phoenix Biotech's after-hype downside and upside margins for the prediction period are 10.87 and 10.87, respectively. We have considered Phoenix Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
10.87
10.87
After-hype Price
10.87
Upside
Phoenix Biotech is very steady at this time. Analysis and calculation of next after-hype price of Phoenix Biotech Acqu is based on 3 months time horizon.

Phoenix Biotech Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Phoenix Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Phoenix Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Phoenix Biotech, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
1 Events / Month
1 Events / Month
Very soon
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
10.87
10.87
0.00 
0.00  
Notes

Phoenix Biotech Hype Timeline

Phoenix Biotech Acqu is at this time traded for 10.87. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Phoenix is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Phoenix Biotech is about 0.0%, with the expected price after the next announcement by competition of 10.87. The company had not issued any dividends in recent years. Assuming the 90 days horizon the next anticipated press release will be very soon.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.

Phoenix Biotech Related Hype Analysis

Having access to credible news sources related to Phoenix Biotech's direct competition is more important than ever and may enhance your ability to predict Phoenix Biotech's future price movements. Getting to know how Phoenix Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Phoenix Biotech may potentially react to the hype associated with one of its peers.

Phoenix Biotech Additional Predictive Modules

Most predictive techniques to examine Phoenix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Phoenix using various technical indicators. When you analyze Phoenix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Phoenix Biotech Predictive Indicators

The successful prediction of Phoenix Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Phoenix Biotech Acquisition, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Phoenix Biotech based on analysis of Phoenix Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Phoenix Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Phoenix Biotech's related companies.

Story Coverage note for Phoenix Biotech

The number of cover stories for Phoenix Biotech depends on current market conditions and Phoenix Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Phoenix Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Phoenix Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Phoenix Biotech Short Properties

Phoenix Biotech's future price predictability will typically decrease when Phoenix Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Phoenix Biotech Acquisition often depends not only on the future outlook of the potential Phoenix Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Phoenix Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding17.9 M
Cash And Short Term Investments475.9 K
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in Phoenix Stock

If you are still planning to invest in Phoenix Biotech Acqu check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Phoenix Biotech's history and understand the potential risks before investing.
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Volatility Analysis
Get historical volatility and risk analysis based on latest market data